Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Naveen Suryadevara"'
Autor:
Kelsey A. Pilewski, Steven Wall, Simone I. Richardson, Nelia P. Manamela, Kaitlyn Clark, Tandile Hermanus, Elad Binshtein, Rohit Venkat, Giuseppe A. Sautto, Kevin J. Kramer, Andrea R. Shiakolas, Ian Setliff, Jordan Salas, Rutendo E. Mapengo, Naveen Suryadevara, John R. Brannon, Connor J. Beebout, Rob Parks, Nagarajan Raju, Nicole Frumento, Lauren M. Walker, Emilee Friedman Fechter, Juliana S. Qin, Amyn A. Murji, Katarzyna Janowska, Bhishem Thakur, Jared Lindenberger, Aaron J. May, Xiao Huang, Salam Sammour, Priyamvada Acharya, Robert H. Carnahan, Ted M. Ross, Barton F. Haynes, Maria Hadjifrangiskou, James E. Crowe, Jr., Justin R. Bailey, Spyros Kalams, Lynn Morris, Ivelin S. Georgiev
Publikováno v:
Cell Reports, Vol 42, Iss 2, Pp 112044- (2023)
Summary: Despite prolific efforts to characterize the antibody response to human immunodeficiency virus type 1 (HIV-1) and hepatitis C virus (HCV) mono-infections, the response to chronic co-infection with these two ever-evolving viruses is poorly un
Externí odkaz:
https://doaj.org/article/1510f5933b314ee292c1c7de93695a93
Autor:
Todd W. Rice, Rachel E. Sutton, Seth J. Zost, Mark R. Denison, Rita E. Chen, Naveen Suryadevara, Wesley H. Self, Jonathan E. Schmitz, Laura J. Stevens, Robert H. Carnahan, Jillian P. Rhoads, Pavlo Gilchuk, Jill M. Pulley, Gordon R. Bernard, Allison P. Wheeler, Isaac P. Thomsen, Michael S. Diamond, James E. Crowe, Sandra Yoder, Eric Brady, James D. Chappell
Publikováno v:
SSRN Electronic Journal.
The COVID-19 pandemic revealed an urgent need for rapid profiling of neutralizing antibody responses and development of antibody therapeutics. The current Food and Drug Administration-approved serological tests do not measure antibody-mediated viral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ab6fbf80849f762c0e09896a7905ad0
https://doi.org/10.2139/ssrn.3878407
https://doi.org/10.2139/ssrn.3878407